CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Oliviero Marinelli

OPENALEX: A5055462856↗ORCID: 0000-0001-5518-5303↗

Affiliations

Organizations

Università di Camerinoauthorship · IT

Public evidence

4 connected articles

Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines.2024 · Europe PMC Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.2021 · Europe PMC Mosquitocidal and Anti-Inflammatory Properties of The Essential Oils Obtained from Monoecious, Male, and Female Inflorescences of Hemp (<i>Cannabis sativa</i> L.) and Their Encapsulation in Nanoemulsions.2020 · PubMed Central Open Access The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.2020 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Oliviero Marinelli - Medical Cannabis Research Engine